News und Analysen

T-Mobile US, Inc. (NASDAQ: TMUS) (“T-Mobile”) announced today that T-Mobile USA, Inc., its direct wholly-owned subsidiary (“T-Mobile USA” or the “Issuer”), has agreed to sell $1,250,000,000

T-Mobile US, Inc. (NASDAQ: TMUS) (“T-Mobile”) announced today that T-Mobile USA, Inc., its direct wholly-owned subsidiary (“T-Mobile USA” or the “Issuer”), has agreed to sell $1,250,000,000

T-Mobile US, Inc. (NASDAQ: TMUS) (“T-Mobile”) announced today that T-Mobile USA, Inc., its direct wholly-owned subsidiary (“T-Mobile USA” or the “Issuer”), plans to offer, subject to market and

T-Mobile US, Inc. (NASDAQ: TMUS) (“T-Mobile”) announced today that T-Mobile USA, Inc., its direct wholly-owned subsidiary (“T-Mobile USA” or the “Issuer”), plans to offer, subject to market and

T-Mobile US, Inc. (NASDAQ: TMUS) (“T-Mobile”) announced today that T-Mobile USA, Inc., its direct wholly-owned subsidiary (“T-Mobile USA” or the “Issuer”), plans to offer, subject to market and

T-Mobile (NASDAQ: TMUS) today announced it has reached an agreement in principle to divest the company’s 800 MHz spectrum portfolio to purchaser Grain Management, LLC, a leading private investment

T-Mobile (NASDAQ: TMUS) today announced it has reached an agreement in principle to divest the company’s 800 MHz spectrum portfolio to purchaser Grain Management, LLC, a leading private investment

T-Mobile (NASDAQ: TMUS) today announced it has reached an agreement in principle to divest the company’s 800 MHz spectrum portfolio to purchaser Grain Management, LLC, a leading private investment

T-Mobile US, Inc. (NASDAQ: TMUS) looks forward to discussing first quarter 2025 financial and operational results on Thursday, April 24, 2025, at 4:30 p.m. Eastern Time (ET). The call will be

T-Mobile US, Inc. (NASDAQ: TMUS) looks forward to discussing first quarter 2025 financial and operational results on Thursday, April 24, 2025, at 4:30 p.m. Eastern Time (ET). The call will be

T-Mobile US, Inc. (NASDAQ: TMUS) looks forward to discussing first quarter 2025 financial and operational results on Thursday, April 24, 2025, at 4:30 p.m. Eastern Time (ET). The call will be

T-Mobile (NASDAQ: TMUS) today announced its latest 25 Hometown Grant recipients, each set to receive up to $50,000 in funding from T-Mobile to support local development projects to revitalize their

T-Mobile (NASDAQ: TMUS) today announced its latest 25 Hometown Grant recipients, each set to receive up to $50,000 in funding from T-Mobile to support local development projects to revitalize their

T-Mobile (NASDAQ: TMUS) today announced its latest 25 Hometown Grant recipients, each set to receive up to $50,000 in funding from T-Mobile to support local development projects to revitalize their

Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced that ICON plc, (NASDAQ: ICLR) a world-leading clinical research

Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced that ICON plc, (NASDAQ: ICLR) a world-leading clinical research

Regulatorische Nachrichten:

Verimatrix (Euronext Paris: VMX), der führende Anbieter von Sicherheitslösungen für die moderne vernetzte Welt, gab heute den Start der Verimatrix XTD Velocity Partner

Everyday Health Group, a division of Ziff Davis, Inc. (NASDAQ: ZD), today announced the acquisition of theSkimm, a leading media brand and suite of products delivering high-value content to

Regulatory News:

Verimatrix, (Euronext Paris: VMX), the leader in powering the modern connected world with people-centered security, today announced the launch of the Verimatrix XTD Velocity

Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today announced its investment in Click Therapeutics, a leader in prescription digital therapeutics and software-enhanced drug therapies

Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today announced its investment in Click Therapeutics, a leader in prescription digital therapeutics and software-enhanced drug therapies

NVIDIA GTC – ServiceNow (NYSE: NOW), the AI platform for business transformation, today announced an expansion of its partnership with NVIDIA to advance agentic AI, building on the companies’

NICE (Nasdaq: NICE) today announced that it was named the Overall Best of Enterprise Connect and recognized for Best Innovation in Customer Experience at Enterprise Connect 2025, a leading